TY - JOUR
T1 - Association between body mass and mortality in maintenance hemodialysis patients
AU - Yen, Tzung Hai
AU - Lin, Ja Liang
AU - Lin-Tan, Dan Tzu
AU - Hsu, Ching Wei
PY - 2010/8
Y1 - 2010/8
N2 - A total of 959 Taiwanese patients undergoing maintenance hemodialysis - 102 underweight (BMI < 18.5 kg/m2), 492 normal weight (BMI 18.5-22.9 kg/m2), 187 overweight (BMI 23.0-24.9 kg/m2), and 178 obese (BMI ≥ 25 kg/m2) were recruited into this three-year, multicenter longitudinal study. It was found initially that the underweight group had more females, longer hemodialysis durations, less use of a biocompatible membrane (BCM) dialyzer, higher erythropoietin doses and Kt/V urea, and lower white blood cell counts, hemoglobin, serum creatinine and phosphate, and high sensitivity C-reactive protein (hsCRP) than other groups (P < 0.001). Furthermore, a χ2-test demonstrated that underweight patients had poorer nutrition (P = 0.023), but less systemic inflammation (P < 0.001) than other groups. A stepwise multiple linear regression analysis established that age, sex, diabetes mellitus, hemodialysis duration, use of BCM dialyzer, Kt/Vurea, creatinine, high-density lipoprotein cholesterol, and hsCRP were significant risk factors associated with BMI (P < 0.001-0.002). After three years, 149 (15.5%) patients had died, including 22 of 102 (21.6%) underweight patients, 64 of 492 (13.0%) normal weight patients, 38 of 187 (20.3%) overweight patients, and 25 of 178 (15.5%) obese patients. The primary causes of mortality were cardiovascular (52.3%) and infection (39.6%). A multivariate Cox regression analysis revealed that age, diabetes mellitus, BMI, albumin, hsCRP, and cardiothoracic ratio were significant risk factors associated with all-cause mortality over three years (P < 0.001-0.022). Finally, Kaplan-Meier analysis confirmed that underweight patients suffer higher mortality than other groups (Log rank, P = 0.0392); therefore, the data have demonstrated a survival disadvantage of low BMI in Taiwanese patients undergoing maintenance hemodialysis.
AB - A total of 959 Taiwanese patients undergoing maintenance hemodialysis - 102 underweight (BMI < 18.5 kg/m2), 492 normal weight (BMI 18.5-22.9 kg/m2), 187 overweight (BMI 23.0-24.9 kg/m2), and 178 obese (BMI ≥ 25 kg/m2) were recruited into this three-year, multicenter longitudinal study. It was found initially that the underweight group had more females, longer hemodialysis durations, less use of a biocompatible membrane (BCM) dialyzer, higher erythropoietin doses and Kt/V urea, and lower white blood cell counts, hemoglobin, serum creatinine and phosphate, and high sensitivity C-reactive protein (hsCRP) than other groups (P < 0.001). Furthermore, a χ2-test demonstrated that underweight patients had poorer nutrition (P = 0.023), but less systemic inflammation (P < 0.001) than other groups. A stepwise multiple linear regression analysis established that age, sex, diabetes mellitus, hemodialysis duration, use of BCM dialyzer, Kt/Vurea, creatinine, high-density lipoprotein cholesterol, and hsCRP were significant risk factors associated with BMI (P < 0.001-0.002). After three years, 149 (15.5%) patients had died, including 22 of 102 (21.6%) underweight patients, 64 of 492 (13.0%) normal weight patients, 38 of 187 (20.3%) overweight patients, and 25 of 178 (15.5%) obese patients. The primary causes of mortality were cardiovascular (52.3%) and infection (39.6%). A multivariate Cox regression analysis revealed that age, diabetes mellitus, BMI, albumin, hsCRP, and cardiothoracic ratio were significant risk factors associated with all-cause mortality over three years (P < 0.001-0.022). Finally, Kaplan-Meier analysis confirmed that underweight patients suffer higher mortality than other groups (Log rank, P = 0.0392); therefore, the data have demonstrated a survival disadvantage of low BMI in Taiwanese patients undergoing maintenance hemodialysis.
KW - Body mass index
KW - End-stage renal disease
KW - Inflammation
KW - Malnutrition
KW - Mortality
UR - http://www.scopus.com/inward/record.url?scp=77955073756&partnerID=8YFLogxK
U2 - 10.1111/j.1744-9987.2010.00818.x
DO - 10.1111/j.1744-9987.2010.00818.x
M3 - 文章
C2 - 20649761
AN - SCOPUS:77955073756
SN - 1744-9979
VL - 14
SP - 400
EP - 408
JO - Therapeutic Apheresis and Dialysis
JF - Therapeutic Apheresis and Dialysis
IS - 4
ER -